Chemical genetics of neuroinflammation: Natural and synthetic compounds as microglial inhibitors

Inflammopharmacology

Volumn 20, Issue 3, 2012, Pages 151-158

  Suk, Kyoungho ^a   Ock, Jiyeon ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Chemical genetics; Microglia; Neurodegenerative diseases; Neuroinflammation; Neuroprotection; Obovatol; Synthetic compounds

Indexed keywords

ANTIINFLAMMATORY AGENT; IMIDAZO[4,5 B]PYRIDINE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KR 31036; KR 31080; KR 31103; KR 31179; KR 31360; KR 31361; KR 35046; KR 35047; KR 35048; KT 14480; KT 15073; KT 15082; KT 15087; KT 16552; KT 16558; KT 16600; KT 16625; KT 17507; KT 17508; KT 17510; OBOVATOL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL ACTIVITY; CHEMICAL GENETICS; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; GENE OVEREXPRESSION; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIPHENYL COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; HUMANS; IMIDAZOLES; INFLAMMATION; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PHENYL ETHERS; PYRIDINES;

EID: 84862996635     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0108-2     Document Type: Review

References (28)

1. Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179
2. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotox-icity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57-69
3. Chang LC, Tsao LT, Chang CS et al (2008) Inhibition of nitric oxide production by the carbazole compound LCY-2-CHO via blockade of activator protein-1 and CCAAT/enhancer-binding protein activation in microglia. Biochem Pharmacol 76:507-519
4. Cho D (2001) Quantitative structure-activity relationship (QSAR) study of new fluorovinylacetamides. Bull Korean Chem Soc 22:388-394
5. Choi MS, Lee SH, Cho HS et al (2007) Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7 cells. Eur J Pharmacol 556:181-189
6. Ito K, Iida T, Ichino K et al (1982) Obovatol and obovatal, novel biphenyl ether lignans from the leaves of Magnolia obovata Thunb. Chem Pharm Bull (Tokyo) 30:3347-3353
7. Kawasumi M, Nghiem P (2007) Chemical genetics: elucidating biological systems with small-molecule compounds. J Invest Dermatol 127:1577-1584
8. Koistinaho M, Koistinaho J (2002) Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40:175-183
9. Lee SK, Kim HN, Kang YR et al (2008) Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem 16:8397-8402
10. Lee M, Cho T, Jantaratnotai N et al (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24:2533-2545
11. Lee M, Kwon BM, Suk K et al (2011) Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage. J Neuroimmune Pharmacol (in press)
12. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27:741-749
13. McGeer PL, McGeer EG (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10(Suppl 1):S3-S7
14. Meng XL, Yang JY, Chen GL et al (2008) RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. Int Immunopharmacol 8:1074-1082
15. Morgan SC, Taylor DL, Pocock JM (2004) Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J Neurochem 90:89-101
16. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318
17. Ock J, Suk K (2010) Anti-inflammatory effects of synthetic compound KT-14480 in lipopolysaccharide-stimulated microglia cells. J Pharm Pharmacol 62:279-285
18. Ock J, Kim S, Suk K (2009) Anti-inflammatory effects of a fluorovinyloxyacetamide compound KT-15087 in microglia cells. Pharmacol Res 59:414-422
19. Ock J, Han HS, Hong SH et al (2010a) Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br J Pharmacol 159:1646-1662
20. Ock J, Hong SH, Suk K (2010b) Identification of KT-15073 as an inhibitor of lipopolysaccharide-induced microglial activation. Biol Pharm Bull 33:461-467
21. Ock J, Kim S, Yi KY et al (2010c) A novel anti-neuroinflammatory pyridylimidazole compound KR-31360. Biochem Pharmacol 79:596-609
22. Pyo MK, Lee Y, Yun-Choi HS (2002) Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch Pharm Res 25:325-328
23. Seo JJ, Lee SH, Lee YS et al (2007) Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog Neuropsycho-pharmacol Biol Psychiatry 31:1363-1369
24. Stockwell BR (2000) Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet 1:116-125
25. Stoll G, Jander S (1999) The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58:233-247
26. Tochtrop GP, King RW (2004) Target identification strategies in chemical genetics. Comb Chem High Throughput Screen 7:677-688
27. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-1015
28. Zheng LT, Ock J, Kwon BM et al (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8:484-494